SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-20-002485
Filing Date
2020-05-15
Accepted
2020-05-15 17:00:59
Documents
11
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6483
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 322839
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 277718
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 6258
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6271
6 EXHIBIT 99.5 exhibit99-5.htm EX-99.5 21571
7 GRAPHIC exhibit99-1x001.jpg GRAPHIC 12290
8 GRAPHIC exhibit99-2x001.jpg GRAPHIC 12135
9 GRAPHIC exhibit99-2x002.jpg GRAPHIC 32911
10 GRAPHIC exhibit99-2x003.jpg GRAPHIC 68855
11 GRAPHIC exhibit99-5x001.jpg GRAPHIC 8940
  Complete submission text file 0001062993-20-002485.txt   828985
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36596 | Film No.: 20886515
SIC: 2834 Pharmaceutical Preparations